Rights and permissions
About this article
Cite this article
FOLFOX trumps FU/LV in stage III colon cancer in Japan. Pharmacoecon. Outcomes News 651, 8 (2012). https://doi.org/10.2165/00151234-201206510-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206510-00020